All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0526 | Anti-CITED2 (CBXC-1519) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | Mouse | CBXC-1519 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0527 | Anti-CITED2 (CBXC-1210) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | Human, Mouse | CBXC-1210 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3950 | Anti-CITED2 (CBXC-1519) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | Mouse | CBXC-1519 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3951 | Anti-CITED2 (CBXC-1210) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | Human, Mouse | CBXC-1210 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1780 | Anti-CITED2 (CBFYM-1009) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Mouse, Rat, Human | CBFYM-1009 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5033 | Anti-CITED2 (CBFYM-1009) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Mouse, Rat, Human | CBFYM-1009 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0494 | Anti-CITED2 (CBWJC-2728) h(41BB-CD3ζ) CAR, pCDCAR1 | Rabbit | Human | CBWJC-2728 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0495 | Anti-CITED2 (JA22) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | JA22 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2786 | Anti-CITED2 (CBWJC-2728) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | Human | CBWJC-2728 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2787 | Anti-CITED2 (JA22) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | JA22 | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION